Comprehending the Unfolded Protein Response as a Conduit for Improved Mesenchymal Stem Cell-Based Therapeutics

被引:0
|
作者
Mullick, Madhubanti [1 ,2 ]
Nayak, Sunita [1 ,2 ]
机构
[1] VIT, CBCMT, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India
[2] VIT, Ctr Biomat Cellular & Mol Theranost, Cellular & Mol Therapeut Lab, Vellore 632014, Tamil Nadu, India
关键词
Mesenchymal stem cells; Endoplasmic reticulum stress; Unfolded protein response; Reactive oxygen species; Hypoxia-reperfusion; Anoikis; ER; TRANSCRIPTION; MITOCHONDRIAL; NRF2; ACTIVATION; MECHANISMS; ISOMERASE; STRESS; IRE1;
D O I
10.1007/s40883-019-00143-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Endoplasmic reticulum (ER) is an intracellular organelle that contributes to efficacious protein synthesis, folding, assembly and transportation. When the normal functions of the ER are perturbed, ER stress is generated which in turn activates an unfolded protein response (UPR). UPR helps in combating this ER stress only at its threshold level, via the inhibition of protein synthesis. This is essentially mediated through increased chaperones and decreased proteins synthesis. Although when the cell undergoes continued ER-stress, UPR ultimately converges to cell-apoptosis, which leads to loss of MSCs viability. Therefore, a delineation into the molecular mechanisms of UPR would be an insightful attempt to curb the prominent loss of MSCs post-transplant. The regenerative potential of MSCs, along with their ubiquitous source of origin, offers vast opportunities with respect to the applications in diverse interdisciplinary sectors of research. But the prevalent loss of MSCs due to certain factors like reactive oxygen species (ROS), hypoxia-reperfusion (H/R), anoikis and inflammation, results in lack of persistence of transplanted MSCs. These hostile conditions contribute to an up surged endoplasmic reticulum stress. Hence, the current review aims at elucidating the mechanisms of the unfolded protein response and its regulation for improving MSCs viability. Lay Summary A major roadblock for successful use of adult stem cells in practice is their poor survivability once introduced in the patient's body. The stem cells tend to die quickly due to stress caused by activation of the unfolded protein response (UPR) pathway. Hence if we can target this UPR pathway (de-activation), then the cells might be able to survive for longer period of time that can help in regeneration of the desired tissue in our body. Future Works Future work can focus on designing therapies that can specifically inhibit UPR activation in stem cells pre and post transplantation such that they are able to survive and help in the desired tissue regeneration inside our body.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [1] Comprehending the Unfolded Protein Response as a Conduit for Improved Mesenchymal Stem Cell-Based Therapeutics
    Madhubanti Mullick
    Sunita Nayak
    [J]. Regenerative Engineering and Translational Medicine, 2020, 6 : 179 - 188
  • [2] Optimizing mesenchymal stem cell-based therapeutics
    Wagner, Joseph
    Kean, Thomas
    Young, Randell
    Dennis, James E.
    Caplan, Arnold I.
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2009, 20 (05) : 531 - 536
  • [3] Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics
    Kumar, Rishabh
    Mishra, Nitin
    Tran, Talan
    Kumar, Munish
    Vijayaraghavalu, Sivakumar
    Gurusamy, Narasimman
    [J]. CELLS, 2024, 13 (10)
  • [4] Mesenchymal and induced pluripotent stem cell-based therapeutics: a comparison
    Teale, Misha A.
    Schneider, Samuel
    Eibl, Dieter
    van den Bos, Christian
    Neubauer, Peter
    Eibl, Regine
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2023, 107 (14) : 4429 - 4445
  • [6] Mesenchymal Stem Cell-Based Therapy
    Mundra, Vaibhav
    Gerling, Ivan C.
    Mahato, Ram I.
    [J]. MOLECULAR PHARMACEUTICS, 2013, 10 (01) : 77 - 89
  • [7] The promise of stem cell-based therapeutics in ophthalmology
    Israel Aharony
    Shalom Michowiz
    Nitza Goldenberg-Cohen
    [J]. Neural Regeneration Research, 2017, 12 (02) : 173 - 180
  • [8] The promise of stem cell-based therapeutics in ophthalmology
    Aharony, Israel
    Michowiz, Shalom
    Goldenberg-Cohen, Nitza
    [J]. NEURAL REGENERATION RESEARCH, 2017, 12 (02) : 173 - 180
  • [9] Stem Cell Metabolism: Powering Cell-Based Therapeutics
    Rigaud, Vagner O. C.
    Hoy, Robert
    Mohsin, Sadia
    Khan, Mohsin
    [J]. CELLS, 2020, 9 (11)
  • [10] Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies
    Selvaraj, Sridhar
    Kyba, Michael
    Perlingeiro, Rita C. R.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2019, 25 (09) : 803 - 816